Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14276 - 14300 of 14610 in total
Experimental
CTS-21166 is a small-molecule beta-secretase inhibitor, which is being developed as a disease-modifying treatment for Alzheimer's disease. CTS-21166 is the only BACE1 inhibitor that has passed Phase I clinical trial thus far. In 2008, CoMentis revealed this small compound as a transition-state analog inhibitor (structure is currently undisclosed) with excellent...
Investigational
Matched Description: … currently undisclosed) with excellent properties in brain penetration, selectivity, metabolic stability, and
Experimental
Experimental
Illicit
Experimental
Experimental
Experimental
Experimental
Experimental
Displaying drugs 14276 - 14300 of 14610 in total